6-acetylaminocaproic acid has been researched along with Alloxan Diabetes in 2 studies
6-acetylaminocaproic acid: wound-healing agent component of plasmutan
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamaguchi, M | 2 |
| Uchiyama, S | 2 |
2 other studies available for 6-acetylaminocaproic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Preventive effect of zinc acexamate administration in streptozotocin-diabetic rats: Restoration of bone loss.
Topics: Alkaline Phosphatase; Aminocaproates; Aminocaproic Acid; Animal Feed; Animals; Body Weight; Bone and | 2003 |
Alteration in serum and bone component findings induced in streptozotocin-diabetic rats is restored by zinc acexamate.
Topics: Aminocaproates; Aminocaproic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; | 2003 |